Penumbra, Inc. Blog | Talkmarkets | Page 1
No data available
No data available

People who follow this stock (34)

Latest Posts

About This Stock More About This Stock
Penumbra Slides 5% After Spruce Point Calls For Up To 55% Downside
Article By: The Fly
Wednesday, July 31, 2019 1:00 PM EST
Shares of Penumbra are down 5% in early trading after short-selling focused research firm Spruce Point issued a short report on the stock, outlining their thesis why the share price is at risk for 40%-55% downside risk.
In this article: PEN
Read
Bull Of The Day: Penumbra (PEN)
Article By: Kevin Cook
Tuesday, September 25, 2018 2:30 PM EST
Penumbra made a strong swing to sustainable profitability this year on the back of projected 27.5% sales growth from last year's $333 million to over $425 million in revenue.
In this article: PEN Also: ABT, BAX, EW, JNJ, MDT, SYK, IART, AXGN, MZOR
Read
Brave Market Volatility With These 5 Low-Beta Stocks
Article By: Zacks Investment Research
Friday, September 21, 2018 3:25 AM EST
It is a common misconception that only risky investments prove rewarding. The strategy works best when the market is bullish.
In this article: HCA, NOA, ECOL, GIII, PEN
Read
Medical Product Stocks Tuesday, May 8 Earnings List: HSIC, PEN & More
Article By: Zacks Investment Research
Tuesday, May 8, 2018 5:47 AM EST
The Medical sector has put up a stellar show so far. It is projected to rise 13.6% on 8.3% revenue growth this earnings season.
In this article: BIO, HAE, HSIC, PEN
Read
E Medical Tech M&A Analysis: Neuro, Orthopedic, Aesthetics And Specialty
Article By: Joe Kunkle
Wednesday, June 8, 2016 7:04 AM EST
In the final part of my series looking at Med-Tech M&A landscape I focus on a diverse group of names, and come to find XENT is the most compelling.
In this article: HAE, CYNO, CNMD, IART, WMGI, ZLTQ, XENT, ENTL, PEN, NVRO Also: LDRH, ZBH
Read

PARTNER HEADLINES

Latest Tweets for $PEN

No tweets yet!